Bioequivalence and Bioavailability Forum

Main page Policy Latest Posts Abbreviations

MDIs formulation [Regulatives / Guidelines]

posted by Mahesh M – India, 2014-12-11 14:45 (4212 d 17:20 ago) – Posting: # 14054
Views: 4,076

Dear All,

Can anyone suggest me what are the reasons for maintaining 30 sec gap between two inhalation (Puffs) in MDIs formulation? (Mentioned in SPC or PI)
And if we maintained the 30 sec gap between two puffs then chances miss to characterize the initial rate of absorption of the drug and the peak concentrations.

Regards

Complete thread:

MDIs formulationMahesh M 2014-12-11 13:45
- MDIs formulation ElMaestro 2014-12-11 13:54
  - MDIs formulation Mahesh M 2014-12-12 06:57
    - MDIs formulation ElMaestro 2014-12-12 09:36

Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
118 visitors (0 registered, 118 guests [including 11 identified bots]).
Forum time: 09:05 CEST (Europe/Vienna)

Scientists often have a naïve faith that
if only they could discover enough facts about a problem,
these facts would somehow arrange themselves
in a compelling and true solution. Theodosius Dobzhansky

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz